Arginine-Selective Bioconjugation Reagent for Effective 18 F-labeling of Native Proteins
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Pragalath Sadasivam und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering and Imaging Sciences, Department of Imaging Chemistry and Biology, King's College, London SE1 7EH, U.K. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Radiopharmaceuticals. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Protein-based 18F-PET tracers offer new possibilities in early disease detection and personalized medicine. Their development relies heavily on the availability and effectiveness of 18F-prosthetic groups. We prepared and evaluated a novel arginine-selective prosthetic group, 4-[18F]fluorophenylglyoxal ([18F]FPG). [18F]FPG was radiosynthesized by a one-pot, two-step procedure with a non-decay-corrected (n.d.c.) isolated radiochemical yield (RCY) of 41 ± 8% (n = 10). [18F]FPG constitutes a generic tool for 18F-labeling of various proteins, including human serum albumin (HSA), ubiquitin, interleukin-2, and interleukin-4 in ∼30-60% n.d.c. isolated RCYs. [18F]FPG conjugation with arginine residues is highly selective, even in the presence of a large excess of lysine, cysteine, and histidine. [18F]FPG protein conjugates are able to preserve the binding affinity of the native proteins while also demonstrating excellent in vivo stability. The [18F]FPG-HSA conjugate has prolonged blood retention, which can be applied as a potential blood pool PET imaging agent. Thus, [18F]FPG is an arginine-selective bioconjugation reagent that can be effectively used for the development of 18F-labeled protein radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering and Imaging Sciences, Department of Imaging Chemistry and Biology, King's College, London SE1 7EH, U.K.
- Institute of Bioengineering and Bioimaging, Agency for Science, Technology, and Research (A* STAR), 11 Biopolis Way, #01-02 Helios, Singapore 138667, Singapore.
- Clinical Imaging Research Centre, 14 Medical Drive, #B01-01 Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- Minerva Imaging ApS, Lyshøjvej 21, Ølstykke 3650, Denmark.
- Molecular Imaging and Therapy Research Unit, South Australian Health, and Medical Research Institute (SAHMRI), North Terrace, Adelaide, SA 5000, Australia.
- Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, North Terrace & George Street, Adelaide, SA 5000, Australia.
ORCID-Profile: Christopher Davis, Edward G Robins, Ran Yan
Förderung
- Wellcome Trust
- Engineering and Physical Sciences Research Council
Zitieren
APA
Sadasivam, P., Khanapur, S., Hartimath, S. V., Ramasamy, B., Cheng, P., Feng, C. Z., Green, D., Davis, C., Goggi, J. L., Robins, E. G., & Yan, R. (2024). Arginine-Selective Bioconjugation Reagent for Effective 18 F-labeling of Native Proteins. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00154
Vancouver
Sadasivam P, Khanapur S, Hartimath SV, Ramasamy B, Cheng P, Feng CZ, et al. Arginine-Selective Bioconjugation Reagent for Effective 18 F-labeling of Native Proteins. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00154
BibTeX
@article{Sadasivam2024,
author = {Sadasivam, Pragalath and Khanapur, Shivashankar and Hartimath, Siddesh V and Ramasamy, Boominathan and Cheng, Peter and Feng, Chin Zan and Green, David and Davis, Christopher and Goggi, Julian L and Robins, Edward G and Yan, Ran},
title = {Arginine-Selective Bioconjugation Reagent for Effective 18 F-labeling of Native Proteins},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00154}
}
EUVIMED